CEO of First Publicly-Traded Cannabis Company in U.S. Discusses Company Strategy, Cannabis Industry Trends and Investment Opportunities
SAN DIEGO, CA–(Marketwired – October 19, 2016) – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s Chief Executive Officer Dr. Stuart Titus was a special guest on Radio America Network’s Equity Strategies show on Sunday, Nov. 6. Dr. Titus spoke to Equity Strategies’ host Stu Taylor about Medical Marijuana Inc.’s history and core competencies, cannabis industry trends and cannabis investing.
Equities Strategies is a radio show that invites corporate executives, authors and entrepreneurs to discuss Company goals and investment opportunities, and also provides listeners with a re-cap of the week’s financial news and market activity.
“I’m thankful for the opportunity to have been on the Equity Strategies’ show to explain how our Company is leading the global cannabis revolution and provide listeners with reasons to get involved in this fast-growing industry with limitless opportunities,” said Dr. Titus. “The entire cannabis industry, including both marijuana and hemp, offers an incredible growth opportunity for astute investors and is helping people who suffer with debilitating conditions across the globe.”
You can listen to a playback of the interview here.
For more information on Radio America Network’s Equities strategy show and host Stu Taylor, visit: http://www.radioamerica.com/program/equity-strategies-2/ and for Medical Marijuana, Inc. visit medicalmarijuanainc.com.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500